Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
Next
New Research, Disorders of the Nervous System

Dopamine development in the mouse orbital prefrontal cortex is protracted and sensitive to amphetamine in adolescence

Daniel Hoops, Lauren M. Reynolds, Jose-Maria Restrepo-Lozano and Cecilia Flores
eNeuro 9 January 2018, ENEURO.0372-17.2017; https://doi.org/10.1523/ENEURO.0372-17.2017
Daniel Hoops
aDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, 6875 LaSalle Boulevard, Montreal, Quebec H4H 1R3, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Hoops
Lauren M. Reynolds
aDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, 6875 LaSalle Boulevard, Montreal, Quebec H4H 1R3, Canada
bIntegrated Program in Neuroscience, McGill University, 1033 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren M. Reynolds
Jose-Maria Restrepo-Lozano
aDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, 6875 LaSalle Boulevard, Montreal, Quebec H4H 1R3, Canada
bIntegrated Program in Neuroscience, McGill University, 1033 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Flores
aDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, 6875 LaSalle Boulevard, Montreal, Quebec H4H 1R3, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cecilia Flores
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Correction: Hoops et al., Dopamine Development in the Mouse Orbital Prefrontal Cortex is Protracted and Sensitive to Amphetamine in Adolescence (eNeuro January/February 2018, 5(1) e0372-17.2017 1-9 https://doi.org/10.1523/ENEURO.0372-17.2017 - February 26, 2018

Abstract

The prefrontal cortex is divided into subregions including the medial and orbital prefrontal cortices. Dopamine connectivity in the medial prefrontal cortex continues to be established throughout adolescence as the result of the continuous growth of axons that innervated the nucleus accumbens prior to adolescence. During this period, dopamine axons remain vulnerable to environmental influences, such as drugs used recreationally by humans. The developmental trajectory of the orbital prefrontal dopamine innervation remains almost completely unstudied. Nonetheless, the orbital prefrontal cortex is critical for some of the most complex functions of the prefrontal cortex and is disrupted by drugs of abuse, both in adolescent humans and rodents. Here, we use quantitative neuroanatomy, axon-initiated viral-vector recombination, and pharmacology in mice to determine the spatiotemporal development of the dopamine innervation to the orbital prefrontal cortex and its vulnerability to amphetamine in adolescence. We find that dopamine innervation to the orbital prefrontal cortex also continues to increase during adolescence and that this increase is due to the growth of new dopamine axons to this region. Furthermore, amphetamine in adolescence dramatically reduces the number of presynaptic sites on orbital prefrontal cortex dopamine axons. In contrast, dopamine innervation to the piriform cortex is not protracted across adolescence and is not impacted by amphetamine exposure during adolescence, indicating that dopamine development during adolescence is a uniquely prefrontal phenomenon. This renders these fibres, and the prefrontal cortex in general, particularly vulnerable to environmental risk factors during adolescence, such as recreational drug use.

Significance Dopamine function in the orbital prefrontal cortex underlies many complex cognitive tasks and is disrupted by drugs of abuse. However, the developmental trajectory of the dopamine innervation to this portion of the prefrontal cortex remains almost completely unstudied. We show that dopamine axons continue to innervate the orbital prefrontal cortex during adolescence. This renders these axons particularly vulnerable to environmental influences. Exposure to amphetamine, at doses equivalent to those used recreationally by adolescent people, reduces the number of dopamine connections in the orbital prefrontal cortex. This effect is selective; it also occurs in the medial prefrontal cortex but not in the piriform cortex. The impact of amphetamine on cortical dopamine development in adolescence appears to be a uniquely prefrontal phenomenon.

  • Drug Use
  • Guidance Cue
  • Orbitofrontal Cortex
  • Piriform Cortex

Footnotes

  • Authors declare no conflict of interest.

  • This work was supported by the National Institute on Drug Abuse (R01DA037911 to CF; F31DA041188 to LMR), the Natural Science and Engineering Research Council of Canada (2982226 to CF), the Canadian Institutes of Health Research (MOP-74709 to CF) and the Quebec Nature and Technology Research Fund (208332 to DH). CF is a research scholar of the Fonds de Recherche du Québec - Santé.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Back to top
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dopamine development in the mouse orbital prefrontal cortex is protracted and sensitive to amphetamine in adolescence
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
View Full Page PDF
Citation Tools
Dopamine development in the mouse orbital prefrontal cortex is protracted and sensitive to amphetamine in adolescence
Daniel Hoops, Lauren M. Reynolds, Jose-Maria Restrepo-Lozano, Cecilia Flores
eNeuro 9 January 2018, ENEURO.0372-17.2017; DOI: 10.1523/ENEURO.0372-17.2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dopamine development in the mouse orbital prefrontal cortex is protracted and sensitive to amphetamine in adolescence
Daniel Hoops, Lauren M. Reynolds, Jose-Maria Restrepo-Lozano, Cecilia Flores
eNeuro 9 January 2018, ENEURO.0372-17.2017; DOI: 10.1523/ENEURO.0372-17.2017
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • drug use
  • guidance cue
  • orbitofrontal cortex
  • piriform cortex

Responses to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Disorders of the Nervous System

  • Expression of HDAC3-Y298H Point Mutant in Medial Habenula Cholinergic Neurons Has No Effect on Cocaine-Induced Behaviors
  • Parallel gene expression changes in ventral midbrain dopamine and GABA neurons during normal aging
  • Demyelination produces a shift in the population of cortical neurons that synapse with callosal oligodendrocyte progenitor cells
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.